B-cell acute lymphoblastic leukemia pediatric · 3 regimens
Cost vs Efficacy · 1 point
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Methylprednisolone monotherapy Variant #02 | — | R 2 802 | 23d | — | — | ~1 | ~R 2 802 indirect | — |
Vincristine and Prednisone Variant #01 | — | R 183 | 5d | — | — | ~1 | ~R 183 indirect | — |
Prednisone monotherapy Variant #11 Partial | — | R 39 | 7d | ~2.2 mo | ~14.1 mo | ~1 | ~R 39 PFS proxy · indirect | 8 |
3 of 3 regimens shown